China A-share innovative drug stocks rally, Yatai Pharma hits daily limit

The breadth of the move across multiple innovative drug names suggests a sector-wide rotation rather than stock-specific news, with Yatai's limit-up acting as a sentiment anchor. This affects traders tracking A-share biotech momentum and institutions gauging risk appetite in the pharma segment. The key watch is whether the rally sustains into the next session or fades as a one-day spike, which would clarify if underlying catalysts or purely technical flows are driving the advance.